About: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $8.86 (-16.38%)
CRBPNASDAQCorbus Pharmaceuticals Holding
Corbus Pharmaceuticals Holding share price
CRBP price activity
Last Price
$8.860
Change (24hr)
-1.74 USD (-16.38%)
Volume
1M
Volume (4w avg)
-
Open
$10.60
Day Range
$8.85 - $10.72
Previous Close
$10.60
Last Trade
09 Sep, 8:10 pm GMT+0
Delayed
09 Sep, 8:10 pm GMT+0
CRBP price performance
Delayed
09 Sep, 8:10 pm GMT+0
CRBP Market Signals